Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-glucosidase from Agrobacterium faecalis is an enzyme that catalyzes the hydrolysis of β-glucosidic bonds in various glucosides, including cellobiose and aryl glucosides, facilitating the release of glucose. It belongs to glycosyl hydrolase family 1 and exhibits a broad specificity for different substrates. Its enzymatic mechanism involves a two-step hydrolysis with formation of a glucosyl-enzyme intermediate, characteristic of retaining glycosidases. This enzyme plays key roles in microbial degradation of cellulose and organic matter in the environment, plant-microbe interactions, and basic research on enzyme mechanisms. This enzyme is primarily of interest for biochemical, ecological, and industrial applications, rather than as a direct human therapeutic target.
Hydrolyzes β-glucosidic bonds via a two-step mechanism involving a glucosyl-enzyme intermediate and oxocarbenium ion-like transition states. Inhibitors such as cyclophellitol bind to the active site and inactivate the enzyme by covalently modifying the catalytic nucleophile.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-glucosidase from Agrobacterium faecalis (None established; commonly referred to as "β-glucosidase" or "Abg" in literature).